Name: UMIN ID:
Unique ID issued by UMIN | UMIN000013122 |
---|---|
Receipt number | R000014068 |
Scientific Title | A randomized phase II study of the efficacy and safety of combination of Bevacizumab/Pemetrexed versus Pemetrexed maintenance therapy in First-Line treatment of elderly patients with advanced or recurrent post-operative non-squamous and non-small cell lung cancer who received Bevacizumab / Pemetrexed induction therapy. |
Date of disclosure of the study information | 2014/02/10 |
Last modified on | 2015/05/28 16:54:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/02/10 16:33:02 | ||
2 | Update | 2015/01/22 13:30:56 | Recruitment status |
|
3 | Update | 2015/05/28 16:54:47 | Institutions |